Literature DB >> 26172555

Pain hypersensitivity and spinal nociceptive hypersensitivity in chronic pain: prevalence and associated factors.

Michele Curatolo1, Monika Müller, Aroosiah Ashraf, Alban Y Neziri, Konrad Streitberger, Ole K Andersen, Lars Arendt-Nielsen.   

Abstract

Hypersensitivity of pain pathways is considered a relevant determinant of symptoms in chronic pain patients, but data on its prevalence are very limited. To our knowledge, no data on the prevalence of spinal nociceptive hypersensitivity are available. We studied the prevalence of pain hypersensitivity and spinal nociceptive hypersensitivity in 961 consecutive patients with various chronic pain conditions. Pain threshold and nociceptive withdrawal reflex threshold to electrical stimulation were used to assess pain hypersensitivity and spinal nociceptive hypersensitivity, respectively. Using 10th percentile cutoff of previously determined reference values, the prevalence of pain hypersensitivity and spinal nociceptive hypersensitivity (95% confidence interval) was 71.2 (68.3-74.0) and 80.0 (77.0-82.6), respectively. As a secondary aim, we analyzed demographic, psychosocial, and clinical characteristics as factors potentially associated with pain hypersensitivity and spinal nociceptive hypersensitivity using logistic regression models. Both hypersensitivity parameters were unaffected by most factors analyzed. Depression, catastrophizing, pain-related sleep interference, and average pain intensity were significantly associated with hypersensitivity. However, none of them was significant for both unadjusted and adjusted analyses. Furthermore, the odds ratios were very low, indicating modest quantitative impact. To our knowledge, this is the largest prevalence study on central hypersensitivity and the first one on the prevalence of spinal nociceptive hypersensitivity in chronic pain patients. The results revealed an impressively high prevalence, supporting a high clinical relevance of this phenomenon. Electrical pain thresholds and nociceptive withdrawal reflex explore aspects of pain processing that are mostly independent of sociodemographic, psychological, and clinical pain-related characteristics.

Entities:  

Mesh:

Year:  2015        PMID: 26172555     DOI: 10.1097/j.pain.0000000000000289

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  6 in total

1.  Pain Catastrophizing is Not Associated With Spinal Nociceptive Processing in People With Chronic Widespread Pain.

Authors:  David A Rice; Rosalind S Parker; Gwyn N Lewis; Michal T Kluger; Peter J McNair
Journal:  Clin J Pain       Date:  2017-09       Impact factor: 3.442

2.  Pain threshold reflects psychological traits in patients with chronic pain: a cross-sectional study.

Authors:  Fumie Kato; Tetsuya Abe; Kenji Kanbara; Ikumi Ban; Tadashi Kiba; Sadanobu Kawashima; Yukie Saka; Yasuyuki Mizuno; Mikihiko Fukunaga
Journal:  Biopsychosoc Med       Date:  2017-05-12

3.  Algometer Assessment of Pressure Pain Threshold After Onabotulinumtoxin-A and Physical Therapy Treatments in Patients With Chronic Migraine: An Observational Study.

Authors:  Manuela Deodato; Antonio Granato; Marta Ceschin; Alessandra Galmonte; Paolo Manganotti
Journal:  Front Pain Res (Lausanne)       Date:  2022-02-10

4.  Does preoperative opioid therapy in patients with a single lumbar disc herniation positively influence the postoperative outcome detected by quantitative sensory testing?

Authors:  Lea Gasser; Sara Lener; Sebastian Hartmann; Wolfgang N Löscher; Claudius Thomé; Anja Hofer
Journal:  Neurosurg Rev       Date:  2022-05-24       Impact factor: 2.800

Review 5.  Chronic Orofacial Pain: Models, Mechanisms, and Genetic and Related Environmental Influences.

Authors:  Barry J Sessle
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

6.  Development and preliminary evaluation of a short self-report measure of generalized pain hypersensitivity.

Authors:  Peter F van Bemmel; Martijn Ah Oude Voshaar; Peter M Ten Klooster; Harald E Vonkeman; Mart Afj van de Laar
Journal:  J Pain Res       Date:  2019-01-17       Impact factor: 3.133

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.